iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Dr Reddy's, Glenmark, and Zydus Recall Products in the US Over Manufacturing Issues

22 Nov 2023 , 03:44 PM

Dr Reddy’s Laboratories, Glenmark Pharma, and Zydus are recalling products in the US market due to manufacturing issues, as per the US Food and Drug Administration (USFDA). 

  • Dr Reddy’s Laboratories, Inc., a unit of the Hyderabad-based firm, is recalling 1,656 bottles of Montelukast sodium tablets used to prevent asthma symptoms. The recall is attributed to the ‘presence of foreign tablets and capsules,’ with a foreign tablet identified as metoprolol 25 mg found in a bottle of Montelukast sodium tablets, USP 10mg.
  • Glenmark Pharmaceuticals Inc, USA, a unit of Mumbai-based Glenmark Pharma, is recalling 5,856 bottles of Deferasirox tablets for oral suspension, used to treat iron overload. The recall is due to ‘failed dissolution specifications.’ Glenmark Pharmaceuticals Inc is also recalling 16,944 bottles of Ranolazine Extended-Release tablets, used for chronic chest pain, in the US due to ‘failed dissolution specifications.’
  • Zydus Pharmaceuticals (USA) Inc is recalling Oxybutynin Chloride extended-release tablets in different strengths due to ‘failed dissolution specifications-out-of-specification test results.’ The affected lot was manufactured by Cadila Healthcare Ltd, Baddi, Himachal Pradesh.

The recalls are classified as Class II, where the use or exposure to the violative product may cause temporary or medically reversible adverse health consequences, with a remote probability of serious adverse health consequences, according to the USFDA.

For feedback and suggestions, write to us at editorial@iifl.com
 

Related Tags

  • Dr Reddys
  • Glenmark
  • news
  • USFDA
  • Zydus
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.